These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13969377)

  • 1. The routine use of alkylating agents for the palliation of advanced cancer.
    BARNES WC
    Am Surg; 1962 Dec; 28():802-5. PubMed ID: 13969377
    [No Abstract]   [Full Text] [Related]  

  • 2. PALLIATION OF MALIGNANT PELVIC DISEASE BY INTRA-AORTIC INJECTION OF NITROGEN MUSTARD (NSC-762) OR ETHOGLUCID (NSC-80439).
    MOORE MR; NEWTON KA
    Cancer Chemother Rep; 1964 Sep; 41():19-22. PubMed ID: 14213135
    [No Abstract]   [Full Text] [Related]  

  • 3. NONSURGICAL TREATMENT OF PULMONARY CANCER.
    KARNOFSKY DA
    Mod Treat; 1964 Mar; 1():369-78. PubMed ID: 14159593
    [No Abstract]   [Full Text] [Related]  

  • 4. Place of chemotherapy in the management of malignant diseases. A retrospective study of 86 cases.
    Gupta BD; Hingorani V; Dhawan IK; Abrol BM
    Indian J Cancer; 1974 Mar; 11(1):54-9. PubMed ID: 4137882
    [No Abstract]   [Full Text] [Related]  

  • 5. STUDIES WITH MUSTARDS. V. IN VIVO FIXATION OF C14 OF LABELED ALKYLATING AGENTS BY BILATERALLY GROWN SENSITIVE AND RESISTANT TUMORS.
    WHEELER GP; ALEXANDER JA
    Cancer Res; 1964 Sep; 24():1331-7. PubMed ID: 14221791
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE EFFECT OF ALKYLATING CYTOSTATICS ON THE NUCLEIC ACID METABOLISM OF EHRLICH ASCITES TUMOR CELLS].
    LISS E; PALME G
    Z Krebsforsch; 1964 Jul; 66():196-206. PubMed ID: 14256642
    [No Abstract]   [Full Text] [Related]  

  • 7. LONG TERM RESULTS ACHIEVED WITH THE USE OF ALKYLATING AGENTS IN MALIGNANT LYMPHOMA AND HODGKIN'S DISEASE.
    PAPAC RJ; WOOD DA
    Acta Unio Int Contra Cancrum; 1964; 20():377-9. PubMed ID: 14151934
    [No Abstract]   [Full Text] [Related]  

  • 8. [NITROGEN MUSTARDS AS ALKYLATING AGENTS].
    MANACORDA G; POMINI A
    Minerva Farm; 1964; 13():89-94. PubMed ID: 14268580
    [No Abstract]   [Full Text] [Related]  

  • 9. THE TREATMENT OF CANCER BY ISOLATION PERFUSION.
    DONALDSON SS; FLETCHER WS
    Am J Nurs; 1964 Aug; 64():81-4. PubMed ID: 14180364
    [No Abstract]   [Full Text] [Related]  

  • 10. EXPERIENCE WITH ALKYLATING AGENTS IN THE TREATMENT OF CHILDREN WITH THE NEPHROTIC SYNDROME.
    COLDBECK JH
    Med J Aust; 1963 Dec; 2():987-9. PubMed ID: 14099134
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative investigation of the chemotherapeutic action of N-oxide-mustard gas and other alkylating compounds in rat tumors].
    DANNEBERG P; DRUCKREY H; KAISER K; LO HW; MECKE R; NIEPER HA; SCHMAHL D
    Arzneimittelforschung; 1956 Sep; 6(9):539-50. PubMed ID: 13373668
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES WITH MUSTARDS. VII. EFFECTS OF ALKYLATING AGENTS IN VITRO AND IN VIVO UPON THE THERMAL PROPERTIES OF DEOXYRIBONUCLEIC ACIDS FROM SENSITIVE AND RESISTANT PLASMACYTOMAS.
    WHEELER GP; STEPHENS ZH
    Cancer Res; 1965 Apr; 25():410-6. PubMed ID: 14281108
    [No Abstract]   [Full Text] [Related]  

  • 13. A catheter technique for intrapleural administration of alkylating agents: a report of ten cases.
    TAYLOR L
    Am J Med Sci; 1962 Dec; 244():706-16. PubMed ID: 13993620
    [No Abstract]   [Full Text] [Related]  

  • 14. THE MANAGEMENT OF ADVANCED CANCER.
    SULLIVAN RD
    Geriatrics; 1965 Jun; 20():485-93. PubMed ID: 14306160
    [No Abstract]   [Full Text] [Related]  

  • 15. EXPECTANCY FOR LIFE IN CHRONIC LYMPHATIC LEUKEMIA.
    GREEN RA; DIXON H
    Blood; 1965 Jan; 25():23-30. PubMed ID: 14255970
    [No Abstract]   [Full Text] [Related]  

  • 16. [ON THE POSSIBILITY OF PROLONGING THE VIABILITY OF SKIN TRANSPLANTS IN RABBITS WITH ALKYLATING SUBSTANCES].
    POPOV VI; NEZDATNYI MM
    Patol Fiziol Eksp Ter; 1964; 8():37-9. PubMed ID: 14184390
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant lymphoma involving the jaw in African children: treatment with alkylating agents and actinomycin D.
    OETTGEN HF; CLIFFORD P; BURKITT D
    Cancer Chemother Rep; 1963 Apr; 28():25-34. PubMed ID: 13939520
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of oxygen tension on the sensitivity of normal and tumor tissues to alkylating agents.
    BACK N; AMBRUS JL
    J Natl Cancer Inst; 1963 Jan; 30():17-29. PubMed ID: 13965953
    [No Abstract]   [Full Text] [Related]  

  • 19. [REFLECTIONS ON THE DEVELOPMENT OF BRONCHOPULMONARY CANCER TREATED BY PALLIATIVE METHODS].
    PLAUCHU M; BRYON PA
    Lyon Med; 1964 Sep; 212():379-87. PubMed ID: 14207153
    [No Abstract]   [Full Text] [Related]  

  • 20. PLASMA CELL NEOPLASM ARISING IN A CAF MOUSE. CHARACTERISTICS AND RESPONSE TO CERTAIN CHEMOTHERAPEUTIC AGENTS.
    YANCEY ST
    J Natl Cancer Inst; 1964 Sep; 33():373-82. PubMed ID: 14207853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.